Irene Kyritsis, NP

Irene Kyritsis practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Irene Kyritsis' NPI, 1508310905, was assigned on August 15, 2016. Irene Kyritsis holds Texas license 1125907.

Irene Kyritsis' primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Irene Kyritsis' primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. Irene Kyritsis is also affiliated with John Sealy Hospital. The medical group on file is Physicians Referral Service. Dmand AI also links Irene Kyritsis to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Irene Kyritsis practices, 2 sites in all. Vendor and product names are available with a free account.

Gerontology is Irene Kyritsis' primary specialty in the NPI Registry, under taxonomy code 363LG0600X. Irene Kyritsis is licensed in Texas.

CMS counts 16 Medicare patients who saw Irene Kyritsis in 2024. 75% of them have cancer, and 75% have high blood pressure. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Irene Kyritsis' median patient age at 73, with 61% women.

In 2024, Irene Kyritsis wrote 380 Medicare Part D claims for 130 patients. 90% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Irene Kyritsis for performance year 2024, reported as part of a group. Irene Kyritsis accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Irene Kyritsis from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $23.